13C-Breath Tests for the Assessment of Liver Function;13C-Basierte Atemtests in der Leberfunktionsdiagnostik

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 3, 2004, Pages 269-275

  Schneider, A R J ^a   Caspary, W F ^a   Stein, Jürgen ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Breath test; Fibrosis; Hepatitis; Liver cirrhosis; Liver function; Stable isotopes

Indexed keywords

4 ACETANISIDINE; AMINOPHENAZONE; CAFFEINE; CARBON 13; CARBON 14; CARBON DIOXIDE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; DIAZEPAM; ERYTHROMYCIN; GALACTOSE; ISOTOPE; METHIONINE; OCTANOIC ACID; PHENACETIN; PHENYLALANINE; CARBON; DIAGNOSTIC AGENT;

ANALYTIC METHOD; BREATH ANALYSIS; DIAGNOSTIC TEST; ENZYME ACTIVITY; HUMAN; LASER ASSISTED RATIO ANALYZER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION; REVIEW; LIVER FUNCTION TEST; METHODOLOGY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

BREATH TESTS; CARBON ISOTOPES; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 1642349907     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-812833     Document Type: Review

References (63)

1. Brockmoller J, Roots I. Assessment of liver metabolic function. Clinical implications. Clin Pharmacokinet 1994; 27: 216-248
2. Armuzzi A, Candelli M, Zocco MA et al. Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther 2002; 16: 1977-1996
3. Caspary WF. Use of breath analysis in diagnosis of liver function. Z Gastroenterol 1978; 16: 188-197
4. Herold C, Berg P, Kupfal D et al. Parameters of microsomal and cytosolic liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients with chronic hepatitis C. Dig Dis Sci 2000; 45: 2233-2237
5. Barth E, Tugtekin I, Weidenbach H et al. Determination of 13CO2/12CO2 ratio by IRMS and NDIRS. Isotopes Environ Health Stud 1998; 34: 209-213
6. Savarino V, Landi F, Dulbecco P et al. Isotope ratio mass spectrometry (IRMS) versus laser-assisted ratio analyzer (LARA): a comparative study using two doses of. Dig Dis Sci 2000; 45: 2168-2174
7. Braden B, Haisch M, Duan LP et al. Clinically feasible stable isotope technique at a reasonable price: analysis of 13CO2/12CO2-abundance in breath samples with a new isotope selective-nondispersive infrared spectrometer. Z Gastroenterol 1994; 32: 675-678
8. Adamek RJ, Goetze O, Boedeker C et al. 13C-methacetin breath test: isotope-selective nondispersive infrared spectrometry in comparison to isotope ratio mass spectrometry in volunteers and patients with liver cirrhosis. Z Gastroenterol 1999; 37: 1139-1143
9. Gisbert JP, Gomollon F, Dominguez-Munoz JE et al. Comparison between two 13C-urea breath tests for the diagnosis of Helicobacter pylori infection: isotope ratio mass spectrometer versus infrared spectrometer. Gastroenterol Hepatol 2003; 26: 141-146
10. Braden B, Gelbmann C, Dietrich CF et al. Qualitative and quantitative clinical evaluation of the laser-assisted ratio analyser for detection of Helicobacter pylori infection by (13)C-urea breath tests. Eur J Gastroenterol Hepatol 2001; 13: 807-810
11. Hepner GW, Vesell ES. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine. Ann Intern Med 1975; 83: 632-638
12. Kotake AN, Starr RM. The in vivo evaluation of the effect of age and sex on the developmental profile of aminopyrine N-demethylase activity in the newborn rat. Drug Metab Dispos 1982; 10: 259-263
13. Heit W. Pyrazolone drugs and agranulocytosis. Agents Actions Suppl 1986; 19: 283-289
14. Fowler PD. Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects. Med Toxicol Adverse Drug Exp 1987; 2: 338-366
15. Saunders JB, Lewis KO, Paton A. Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test. Gastroenterology 1980; 79: 112-114
16. Merkel C, Morabito A, Sacerdoti D et al. Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol 1998; 30: 276-282
17. Saunders JB, Wright N, Lewis KO. Predicting outcome of paracetamol poisoning by use 14C-aminopyrine breath test. Br Med J 1980; 280: 279-280
18. Giannini E, Fasoli A, Chiarbonello B et al. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 2002; 16: 717-725
19. Herold C, Heinz R, Niedobitek G et al. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. Liver 2001; 21: 260-265
20. Fasoli A, Giannini E, Botta F et al. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis. Hepatogastroenterology 2000; 47: 234-238
21. Wensing G, Lotterer E, Link I et al. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function. Hepatology 1997; 26: 1149-1155
22. Wensing G, Sabra R, Branch RA. Relationship between oxidative hepatic metabolism, urinary sodium excretion and sympathetic nerve activity in experimental cirrhosis in the rat. Z Gastroenterol 1995; 33: 1-4
23. Baker AL, Krager PS, Kotake AN et al. The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis. Hepatology 1987; 7: 464-467
24. Herold C, Ganslmayer M, Deynet C et al. Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis. Liver 2002; 22: 159-165
25. Hepner GW, Vesell ES. Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis. N Engl J Med 1974; 291: 1384-1388
26. Herz R, Koelz HR, Haemmerli UP et al. Inhibition of hepatic demethylation of aminopyrine by oral contraceptive steroids in humans. Eur J Clin Invest 1978; 8: 27-30
27. Dossing M, Pilsgaard H, Rasmussen B et al. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism. Eur J Clin Pharmacol 1983; 25: 215-222
28. Herold C, Ganslmayer M, Ocker M et al. Inducibility of microsomal liver function may differentiate cirrhotic patients with maintained compared with severely compromised liver reserve. J Gastroenterol Hepatol 2003; 18: 445-449
29. Van Vlierberghe H, Van Durme F, Verdievel H et al. Influence of low-dose oral contraceptives, alcohol, and grapefruit on. Dig Dis Sci 2001; 46: 133-139
30. Schneider JF, Schoeller DA, Schreider BD et al. Use of 13C-phenacetin and 13C-methacetin for the detection of alterations in hepatic drug metabolism. In: Klein ER, Klein PD (Hrsg). Stable Isotopes: Proceedings of the Third International Conference. New York: Academic Press, 1979: 507-516
31. Klatt S, Taut C, Mayer D et al. Evaluation of the 13C-methacetin breath test for quantitative liver function testing. Z Gastroenterol 1997; 35: 609-614
32. Ciccocioppo R, Candelli M, Di Francesco D et al. Study of liver function in healthy elderly subjects using the 13C-methacetin breath test. Aliment Pharmacol Ther 2003; 17: 271-277
33. Lown KS, Kolars JC, Thummel KE et al. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test. Drug Metab Dispos 1994; 22: 947-955
34. Lown KS, Bailey DG, Fontana RJ et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997; 99: 2545-2553
35. Hunt CM, Watkins PB, Saenger P et al. Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol. Clin Pharmacol Ther 1992; 51: 18-23
36. Hunt CM, Westerkam WR, Stave GM et al. Hepatic cytochrome P-4503A (CYP3A) activity in the elderly. Mech Ageing Dev 1992; 64: 189-199
37. Watkins PB, Hamilton TA, Annesley TM et al. The erythromycin breath test as a predictor of cyclosporine blood levels. Clin Pharmacol Ther 1990; 48: 120-129
38. Haas CE, Kaufman DC, Jones CE et al. Cytochrome P450 3A4 activity after surgical stress. Crit Care Med 2003; 31: 1338-1346
39. Cakaloglu Y, Tredger JM, Devlin J et al. Importance of cytochrome P-450111A activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients. Hepatology 1994; 20: 309-316
40. Schmidt LE, Olsen AK, Stentoft K et al. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients. Clin Pharmacol Ther 2001; 70: 446-454
41. Branch RA. Drugs as indicators of hepatic function. Hepatology 1982; 2: 97-105
42. Tanaka E, Breimer DD. In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease. J Clin Pharm Ther 1997; 22: 237-249
43. Willson RA, Hart FE. The comparison of in vivo plasma radioactivity clearance and 14CO2 breath elimination of model drugs in the rat: a study in regional hepatocyte function. Toxicol Appl Pharmacol 1981; 61: 177-184
44. Wietholtz H, Voegelin M, Arnaud MJ et al. Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test. EurJ Clin Pharmacol 1981; 21: 53-59
45. Fontana RJ, Turgeon DK, Woolf TF et al. The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity. Hepatology 1996; 23: 1429-1435
46. Herold C, Heinz R, Radespiel-Troger M et al. Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity. Liver 2001; 21: 26-30
47. Caspary WF, Schaffer J. 14C-D-galactose breath test for evaluation of liver function in patients with chronic liver disease. Digestion 1978; 17: 410-418
48. Ishii Y, Asai S, Kohno T et al. 13CO(2) peak value of L-[1-(13)C]phenylalanine breath test reflects hepatopathy. J Surg Res 1999; 86: 130-135
49. Ishii Y, Asai S, Kohno T et al. Recovery of liver function in two-third partial hepatectomized rats evaluated by L-[1-13C]phenylalanine breath test. Surgery 2002; 132: 849-856
50. Kobayashi T, Kubota K, Imamura H et al. Hepatic phenylalanine metabolism measured by the [13C] phenylalanine breath test. Eur J Clin Invest 2001; 31: 356-361
51. Burke PA, Stack JA, Wagner D et al. L-[1-(13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg 1997; 173: 270-273
52. Tugtekin I, Wachter U, Barth E et al. Phenylalanine kinetics in healthy volunteers and liver cirrhotics: implications for the phenylalanine breath test. Am J Physiol Endocrinol Metab 2002; 283: E1223-E1231
53. Epstein CM, Chawla RK, Wadsworth A et al. Decarboxylation of alpha-ketoisovaleric acid after oral administration in man. Am J Clin Nutr 1980; 33: 1968-1974
54. Michaletz PA, Cap L, Alpert E et al. Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid. Hepatology 1989; 10: 829-832
55. Bendtsen P, Hannestad U, Pahlsson P. Evaluation of the carbon 13-labeled Ketoisocaproate breath test to assess mitochondrial dysfunction in patients with high alcohol consumption. Alcohol Clin Exp Res 1998; 22: 1792-1795
56. Witschi A, Mossi S, Meyer B et al. Mitochondrial function reflected by the decarboxylation of [13C]ketoisocaproate is impaired in alcoholics. Alcohol Clin Exp Res 1994; 18: 951-955
57. Honkoop P, de Man RA, Scholte HR et al. Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B. Hepatology 1997; 26: 211-215
58. Miele L, Grieco A, Armuzzi A et al. 13C-Octanoate breath test to assess hepatic mitochondrial beta-oxidation in patients with nonalcoholic steato-hepatitis. Gut 2000 (Suppl. III): A134-A135
59. Armuzzi A, Zocco MA, Miele L et al. Assessment of liver mitochondrial beta-oxidation by sodium 13C-Octanoate breath test. Hepatology 2000; 32 (Supplement 2): 122
60. Ishii Y, Asai S, Kohno T et al. Evaluation of liver regeneration using the L-[1-13C]methionine breath test. J Surg Res 2001; 95: 195-199
61. Armuzzi A, Marcoccia S, Zocco MA et al. Non-Invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test. Scand J Gastroenterol 2000; 35: 650-653
62. Caspary WF. Breath-analysis tests in gastroenetrological diagnosis. Z Gastroenterol 1975; 13: 704-714
63. Klein PD. 13C breath tests: visions and realities. J Nutr 2001; 131: 1637S-1642S